MedTrace Logo

Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.

NCT06114121 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2024-09-19

No results posted yet for this study

Summary

The objective of the study is to optimize post-operative analgesia and improve patient satisfaction while reducing total opioid consumption after cesarean section

Conditions

  • Post-operative Pain

Interventions

PROCEDURE

erector spinae plane block (ESP)

nerve block for abdominal pain. administered once immediately prior to spinal anesthetic standard of care.

DRUG

Duramorph

100 micrograms (mcg) of morphine administered in the spinal medications one time.

DRUG

Ropivacaine

Ropivacaine 0.5% between 20-40 milliliters will be administered once in the ESP block (in the spine) depending on patient weight to keep under the maximum dose.

DRUG

Bupivacaine Injection

Bupivacaine 0.75% 1.4-1.7 milliliters (10-12 milligrams) spinal medication. administered one time.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Reine Zbeidy, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-10
Primary Completion
2024-09-10
Completion
2024-09-10
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06114121 on ClinicalTrials.gov